Impact of long-term statin pretreatment on myocardial damage in St elevation myocardial infarction (from the AIDA STEMI CMR substudy)

Georg Fuernau*, Ingo Eitel, Jochen Wöhrle, Sebastian Kerber, Bernward Lauer, Matthias Pauschinger, Johannes Schwab, Ralf Birkemeyer, Stefan Pfeiffer, Meinhard Mende, Oana Brosteanu, Petra Neuhaus, Steffen Desch, Suzanne De Waha, Matthias Gutberlet, Gerhard Schuler, Holger Thiele

*Korrespondierende/r Autor/-in für diese Arbeit
7 Zitate (Scopus)

Abstract

Nonrandomized studies suggested lower mortality rates with statin pretreatment in patients with acute ST elevation myocardial infarction (STEMI). However, clinical data are still inconclusive and the mechanisms of these presumed beneficial effects require further exploration. Cardiac magnetic resonance (CMR) imaging offers the possibility of studying a variety of markers of myocardial damage and reperfusion injury after myocardial infarction. The aim of this study was to assess a possible link of statin pretreatment with myocardial damage in acute STEMI. The multicenter Abciximab i.v. versus i.c. in ST-elevation Myocardial Infarction CMR substudy enrolled 795 consecutive patients with acute STEMI who underwent primary angioplasty within 12 hours of symptom onset. CMR studies assessing left ventricular ejection fraction, infarct size, microvascular obstruction, area at risk, and myocardial salvage index were performed in a median of 3 days after the clinical event. We performed a retrospective analysis to evaluate the impact of statin pretreatment on myocardial damage. Information on statin pretreatment was available in 791 of 795 patients (99%). Of these, 122 (15%) had long-term statin pretreatment. CMR results showed no significant differences in the area at risk, left ventricular ejection fraction, infarct size, microvascular obstruction, and myocardial salvage index between patients with and without statin pretreatment. Furthermore, no differences in short- and long-term outcomes could be observed. In conclusion, in this CMR study, statin pretreatment in patients with STEMI was not associated with lesser myocardial damage.

OriginalspracheEnglisch
ZeitschriftAmerican Journal of Cardiology
Jahrgang114
Ausgabenummer4
Seiten (von - bis)503-509
Seitenumfang7
ISSN0002-9149
DOIs
PublikationsstatusVeröffentlicht - 15.08.2014

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Impact of long-term statin pretreatment on myocardial damage in St elevation myocardial infarction (from the AIDA STEMI CMR substudy)“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren